GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » Price-to-Owner-Earnings

Adcock Ingram Holdings (JSE:AIP) Price-to-Owner-Earnings : 13.96 (As of Jun. 19, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings Price-to-Owner-Earnings?

As of today (2024-06-19), Adcock Ingram Holdings's share price is R59.89. Adcock Ingram Holdings's Owner Earnings per Share (TTM) ended in Jun. 2023 was R4.29. It's Price-to-Owner-Earnings for today is 13.96.


The historical rank and industry rank for Adcock Ingram Holdings's Price-to-Owner-Earnings or its related term are showing as below:

JSE:AIP' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.73   Med: 26.29   Max: 122.27
Current: 13.47

During the past 13 years, the highest Price-to-Owner-Earnings of Adcock Ingram Holdings was 122.27. The lowest was 10.73. And the median was 26.29.


JSE:AIP's Price-to-Owner-Earnings is ranked better than
77.23% of 426 companies
in the Drug Manufacturers industry
Industry Median: 24.73 vs JSE:AIP: 13.47

As of today (2024-06-19), Adcock Ingram Holdings's share price is R59.89. Adcock Ingram Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was R5.49. Therefore, Adcock Ingram Holdings's PE Ratio for today is 10.90.

As of today (2024-06-19), Adcock Ingram Holdings's share price is R59.89. Adcock Ingram Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was R548.72. Therefore, Adcock Ingram Holdings's PE Ratio without NRI for today is 0.11.

During the past 13 years, Adcock Ingram Holdings's highest PE Ratio without NRI was 28.64. The lowest was 0.09. And the median was 14.65.


Adcock Ingram Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Adcock Ingram Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings Price-to-Owner-Earnings Chart

Adcock Ingram Holdings Annual Data
Trend Sep13 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.04 13.46 28.71 13.90 13.14

Adcock Ingram Holdings Semi-Annual Data
Mar14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 13.90 - 13.14 -

Competitive Comparison of Adcock Ingram Holdings's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adcock Ingram Holdings's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's Price-to-Owner-Earnings falls into.



Adcock Ingram Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Adcock Ingram Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=59.89/4.29
=13.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adcock Ingram Holdings  (JSE:AIP) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Adcock Ingram Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings (JSE:AIP) Business Description

Traded in Other Exchanges
N/A
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.